Strides Pharma Science is preparing to enhance its presence in Sub-Saharan Africa by acquiring branded generic products from Sandoz AG, with an initial investment of USD 12 million. This strategic move is expected to catapult Strides into the ranks of the top five pharmaceutical firms in the region.